At first glance, it may seem as if the world will soon have more than enough COVID-19 vaccines. Manufacturers have produced approximately ten billion individual doses since states began approving inoculations in the middle of 2020.
On May 5, President Joe Biden announced that the United States would support an international bid to waive intellectual property rights to vaccines for the duration of the coronavirus pandemic, thereby ostensibly allowing other countries to ramp up production even of the sophisticated technology beh...
India faces a seemingly mammoth COVID-19 vaccination challenge, but its progress so far suggests it may be well equipped to handle the task. Other countries seeking to protect their populations from the pandemic should draw at least three lessons from India's efforts.
Ideas to action: independent research for global prosperity